Skip to main content

Table 1 Peptide sequences of  m/z  4223.1 determined from the LC-MS/MS analysis

From: Protective effect of the Japanese traditional medicine juzentaihoto on myelosuppression induced by the anticancer drug TS-1 and identification of a potential biomarker of this effect

A Matched mass Computed mass Residues Sequence
  1735.8 1735.7 570-584 K.TVMDDFAQFLDTCCK. A
  1751.7 1751.7 570-584 K.TVMDDFAQFLDTCCK.A Oxidation (M)
  1923.9 1923.9 585-602 K.AADKDTCFSTEGPNLVTR.C
  1995.0 1994.9 585-602 K.AADKDTCFSTEGPNLVTR.C Propionamide (C)
  1538.7 1538.7 589-602 K.DTCFSTEGPNLVTR.C
B 551 TALAELVKHK PKATAEQLKT VMDDFAQFLD TCCKAADKDT CFSTEGPNLV
  601 TR CKDALA
  1. A) Peptide sequences determined from LC-MS/MS analysis. B) Amino acid sequence of the C-terminal peptide (from residue 551 to 608) of mouse albumin (Swiss-Prot entry P07724). Matched peptides shown in Bold.